Ex parte BRUXVOORT et al. - Page 18


                 Appeal No. 95-1622                                                                                                                     
                 Application 07/890,593                                                                                                                 

                          We find that declarant McCormick further states the ratios of molar equivalents of                                            
                 organometallic groups to nucleophilic groups for all of the Wright Examples (¶ 24), and states the                                     
                 descriptions of the “adhesion” set forth in certain of these Examples (¶ 25).  Declarant Wright concludes                              
                 that “[t]hese variable [descriptive] results do not seem to correlate with metal/nucleophilic ratios . . .                             
                 [and] [i]f Wright’s compositions adhered by our mechanism the results . . . should be more consistent                                  
                 in providing good adhesion” (¶ 26; emphasis ours).  We find that declarant McCormick’s conclusions                                     
                 are, in this instance, based on subjective rather than objective evidence.                                                             
                          Declarant McCormick does conclude that “example 18 of Wright is the only example that does                                    
                 not use an excess of nucleophile and it was coated on polyester which would not be one or our useful                                   
                 substrates” (¶ 25).  The molar ratio of organometallic groups to nucleophilic groups in Wright Example                                 
                 18 is stated to be “1/0.52” (¶ 24) and while not included in the list of adhesion descriptions attributed to                           
                 Wright (¶ 25), we find that Wright describes the result of irradiating the dried coating of organometallic                             
                 polymer and the polynucleophilic 1,2-bis(diphenylphosphino)-ethane on “75 µm polyester film” as                                        
                 “extremely good adhesion” (col. 17, lines 4-15).  We cannot agree with declarant McCormick that the                                    
                 polyester substrate used in Wright Example 18 is excluded by appealed claim 2 or not disclosed in                                      
                 appellants’ specification.  Indeed, as we found above (see supra note 8), it appears that the “75 µm                                   
                 polyester film” is “primed” with “[v]apor coated aluminum” which, of course, would provide basic                                       
                 reactive sites as required by appealed claim 2 and as disclosed in appellants’ specification (page 19,                                 
                 lines 3-4 and 11).  We further find no reasonable basis to exclude Wright Example 18 from                                              
                 consideration based on the “polyester” substrate since that same substrate is included in Wright                                       
                 Examples 9, 11-14 and 17 which are stated to be represented by solution 1 in declaration Example B                                     
                 (¶ 19).                                                                                                                                
                          It is well settled that the burden of establishing the significance of data in the record, with respect                       
                 to unexpected results or for other purposes, rests with appellants, which burden is not carried by mere                                
                 arguments of counsel or conclusionary statements by declarant.  See generally In re Geisler, 116 F.3d                                  
                 1465, 1470, 43 USPQ2d 1362, 1365-66 (Fed. Cir. 1997); In re Huang, 100 F.3d 135, 140, 40                                               
                 USPQ2d 1685, 1689-90 (Fed. Cir. 1996); In re Merck, 800 F.2d 1091, 1099, 231 USPQ 375, 381                                             
                 (Fed. Cir. 1986); In re Longi, 759 F.2d 887, 897, 225 USPQ 645, 651-52 (Fed. Cir. 1985); In re                                         

                                                                        - 18 -                                                                          



Page:  Previous  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  Next 

Last modified: November 3, 2007